Paul Voigt has taken on the role of Interim CEO at Innovate Corp., whose growth is being driven by MediBeacon's system, amid increased interest from the FDA.
2 reports, 1 independent
Updated Aug 6
Gone quiet
- Reports
- 2
- Developments
- 1
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Paul Voigt has taken on the role of Interim CEO at Innovate Corp., whose growth is being driven by MediBeacon's system, amid increased interest from the FDA.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Paul Voigt
German lawyer and consultant focused on information technology law, personal data protection, data protection, information and cybersecurity security, risk management in the field of e-commerce, especially in multinational companies.
Nothing else this week.
-
Innovate Corp.
American financial services and holding company
Nothing else this week.
- FDA
Coverage
Newest first; wire copies grouped- GlobeNewswireINNOVATE Corp. Announces Second Quarter 2025 Results - Infrastructure: Improved financial flexibility with recent refinancing transactions - - Life Sciences: R2 continuing to see significant year ove
- GlobeNewswireINNOVATE Closes Indebtedness Refinancing Transactions INNOVATE’s Maturity Profile Has Been Successfully Extended NEW YORK, Aug. 04, 2025 (GLOBE NEWSWIRE) -- INNOVATE Corp. (NYSE: VATE) (“INNOVATE” or